| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 0.0 | 0.0 | 0.0 |
| Other income | 1.4 | 0.0 | 0.0 |
| Total income | 1.4 | 0.0 | 0.0 |
| Profit before exceptional items & tax | -6.4 | -2.6 | -1.8 |
| Profit before tax | -6.4 | -2.6 | -1.8 |
| Net profit | -6.4 | -3.0 | -1.8 |
| Operating margin | -457.1% | 0.0% | 0.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Operating profit, year on year | -333.30% |
|---|---|
| Operating profit, quarter on quarter | -200.00% |
NSE results filing, NSE: SRPL. Figures extracted from the filing.
More from Shree Ram Proteins Limited
All →Shree Ram Proteins Board Meeting Date
Shree Ram Proteins Limited scheduled a board meeting for 17-Aug-2026. The meeting will consider the company's unaudited financial results for the quarter ended June 2026.
Shree Ram Proteins Annual General Meeting
Shree Ram Proteins Ltd has issued a postal ballot notice seeking shareholder approval for the sale of its undertaking for an approximate consideration of ₹17 Crore.
- Value
- ₹17.00 Cr
Shree Ram Proteins Annual General Meeting
Shree Ram Proteins Limited has issued a postal ballot notice seeking shareholder approval for the sale or disposal of the whole or substantially the whole undertaking.
Shree Ram Proteins Merger & Restructuring Worth ₹17 Cr
Shree Ram Proteins Limited board has approved the sale or transfer of its whole undertaking for approximately ₹17.00 Crore. The transaction is subject to shareholder approval.
- Value
- ₹17.00 Cr
Shree Ram Proteins Board Meeting Date
Shree Ram Proteins Limited has rescheduled its board meeting to August 17, 2026. The meeting will discuss yearly audited financial results.
Shree Ram Proteins Board Meeting Date
Shree Ram Proteins rescheduled its board meeting to July 31, 2026. The meeting will consider audited standalone financial results for the year ended March 2026.